Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma

This publication has 25 references indexed in Scilit:

• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
  Science, 2006
• Adoptive immunotherapy for cancer: building on success
  Nature Reviews Immunology, 2006
• Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation
  Blood, 2006
• L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers
  The Journal of cell biology, 2005
• Extracellular Signal-regulated Kinase (ERK)-dependent Gene Expression Contributes to L1 Cell Adhesion Molecule-dependent Motility and Invasion
  Journal of Biological Chemistry, 2004
• Genetic engineering of cytolytic T lymphocytes for adoptive T‐cell therapy of neuroblastoma
  The Journal of Gene Medicine, 2004
• Nonmyeloablative Immunosuppressive Regimen Prolongs In Vivo Persistence of Gene-Modified Autologous T Cells in a Nonhuman Primate Model
  Journal of Virology, 2001
• Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3.
  The Journal of cell biology, 1996
• Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
  Science, 1992
• Production and characterization of monoclonal antibodies against human neuroblastoma
  International Journal of Cancer, 1986